Vivos Therapeutics (VVOS)
(Delayed Data from NSDQ)
$4.76 USD
-0.42 (-8.11%)
Updated Aug 4, 2025 03:59 PM ET
After-Market: $4.70 -0.06 (-1.26%) 6:16 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Vivos Therapeutics, Inc. has a market cap of $30.51M, which represents its share price of $5.18 multiplied by its outstanding shares number of 5.89M. As a small-cap company, VVOS's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
VVOS 4.76 -0.42(-8.11%)
Will VVOS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VVOS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VVOS
Ionis Pharmaceuticals (IONS) Q2 Earnings and Revenues Beat Estimates
Vivos Therapeutics, Inc. (VVOS) Reports Q1 Loss, Lags Revenue Estimates
VVOS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nektar Therapeutics (NKTR) Reports Q1 Loss, Lags Revenue Estimates
Vivos Therapeutics, Inc. (VVOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Vivos Therapeutics, Inc. (VVOS) Reports Q4 Loss, Lags Revenue Estimates
Other News for VVOS
Vivos Therapeutics (VVOS) Strengthens Leadership with Key Appointments
Vivos Therapeutics appoints Bruhn as EVP, Jones as SVP
12 Health Care Stocks Moving In Tuesday's Intraday Session